Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, briefly outlines the risk factors for Richter's transformation (RT), including complex karyotype, TP53 abberation, the metabolism in chronic lymphocytic leukemia (CLL) cells, as well as the tumor microenvironment and T-cell function. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Risk-factors for Richter’s transformation
Теги
Speaker: Barbara EichhorstInstitution: University Hospital CologneEvent: ASH 2023Format: InterviewSubject: Chronic Lymphocytic LeukemiaSubject: LeukemiaMedicines: ZanubrutinibMedicines: TislelizumabMedicines: AntibodiesMedicines: BTK inhibitorsField: TreatmentField: Trial UpdatesField: Immuno-oncologyTrial: CLL-RT1NCT04271956BTK inhibitorsmonoclonal antibodiesRichter’s transformationRTTP53 mutationcomplex karyotypeECOG score